HIV-1 infection: Fooling the gatekeeper

Nature Medicine

Volumn 9, Issue 9, 2003, Pages 1112-1113

  Cullen, Bryan R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; CYCLOPHILIN A;

CELLULAR IMMUNITY; FV1 GENE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONKEY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN INTERACTION; RETROVIRUS; SHORT SURVEY; VIRION; VIRUS ADSORPTION; VIRUS CAPSID; VIRUS GENE; VIRUS REPLICATION;

ANIMALS; CYCLOPHILIN A; CYCLOSPORINE; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; GENETIC PREDISPOSITION TO DISEASE; HIV INFECTIONS; HIV-1; HUMANS; LEUKEMIA VIRUS, MURINE; MICE; PRIMATES; PROTEINS; RETROVIRIDAE; VIRION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; PYRONIA TITHONUS; UNIDENTIFIED RETROVIRUS;

EID: 0141737480     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0903-1112     Document Type: Short Survey

References (8)

1. Towers, G.J. et al. Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors. Nat. Med. 9, 1138-1143 (2003).
2. Goff, S.P. Operating under a Gag order: a block against incoming virus by the Fv1 gene. Cell 86, 691-693 (1996).
3. Towers, G. et al. A conserved mechanism of retrovirus restriction. Proc. Natl. Acad. Sci. USA 97, 12295-12299 (2000).
4. Cowan, S. et al. Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism. Proc. Natl. Acad. Sci. USA 99, 11914-11919 (2002).
5. Besnier, C., Takeuchi, Y. & Towers, G. Restriction of lentivirus in monkeys. Proc. Natl. Acad. Sci. USA 99, 11920-11925 (2002).
6. Münk, C., Brandt, S.M., Lucero, G. & Landau, N.R. A dominant block to HIV-1 replication at reverse transcription in simian cells. Proc. Natl. Acad. Sci. USA 99, 13843-13848 (2002).
7. Luban, J. et al. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell 73, 1067-1078 (1993).
8. Braaten, D., Franke, E.K. & Luban J. Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription. J. Virol. 70, 3551-3560 (1996).